Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -6.48 is 54% above its 5-year average of -13.98, near the high end of its 5-year range (-42.72–-3.68).
35.28% below its 12-month average of -4.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.81.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-6.48
EARNINGS PER SHARE (EPS) AVG TTM
-4.79
EARNINGS PER SHARE (EPS) AVG 3Y
-7.51
EARNINGS PER SHARE (EPS) AVG 5Y
-13.98
EARNINGS PER SHARE (EPS) AVG 10Y
-17.20
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.28%
CURRENT VS 3Y AVG
+13.72%
CURRENT VS 5Y AVG
+53.65%
CURRENT VS 10Y AVG
+62.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$104.68M
Earnings Per Share (EPS)
-6.48
TTM Avg
-4.79
3Y Avg
-7.51
5Y Avg
-13.98
Market Cap
$106.83M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.33
3Y Avg
-0.37
5Y Avg
-0.32
Market Cap
$105.15M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.42
3Y Avg
-1.68
5Y Avg
-1.45
Market Cap
$109.24M
Earnings Per Share (EPS)
N/A
TTM Avg
-5.70
3Y Avg
-9.83
5Y Avg
-0.70
Market Cap
$107.15M
Earnings Per Share (EPS)
-0.74
TTM Avg
-0.44
3Y Avg
-1.32
5Y Avg
-1.80
Market Cap
$109.91M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.47
3Y Avg
-0.54
5Y Avg
-0.49
Market Cap
$102.56M
Earnings Per Share (EPS)
0.27
TTM Avg
-0.10
3Y Avg
-0.20
5Y Avg
0.10
Market Cap
$108.43M
Earnings Per Share (EPS)
-4.80
TTM Avg
-8.13
3Y Avg
-18.81
5Y Avg
-23.77
Market Cap
$111.72M
Earnings Per Share (EPS)
-3.21
TTM Avg
-1.79
3Y Avg
-1.14
5Y Avg
-1.14
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $104.68M | -6.48 | -4.79 | -7.51 | -13.98 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.83M | -0.71 | -0.33 | -0.37 | -0.32 |
| Definitive Healthcare Corp. (DH)vs › | $105.15M | -1.60 | -2.42 | -1.68 | -1.45 |
| BGM Group Ltd. (BGM)vs › | $109.24M | N/A | -5.70 | -9.83 | -0.70 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.15M | -0.74 | -0.44 | -1.32 | -1.80 |
| Apyx Medical Corporation (APYX)vs › | $109.91M | -0.21 | -0.47 | -0.54 | -0.49 |
| The Joint Corp. (JYNT)vs › | $102.56M | 0.27 | -0.10 | -0.20 | 0.10 |
| Immunic, Inc. (IMUX)vs › | $108.43M | -4.80 | -8.13 | -18.81 | -23.77 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.72M | -3.21 | -1.79 | -1.14 | -1.14 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $109.21M | -0.99 | -1.38 | -1.93 | -2.07 |
Trailing EPS (TTM)
$-6.48
Forward EPS (Est.)
$-5.43
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.90 |
| 2024-12-31 | -3.68 |
| 2023-12-31 | -10.31 |
| 2022-12-31 | -10.15 |
| 2021-12-31 | -11.13 |
| 2020-12-31 | -42.72 |
| 2019-12-31 | -33.55 |
| 2018-12-31 | -29.30 |
| 2017-12-31 | -19.38 |
| 2016-12-31 | -14.58 |
| 2015-12-31 | -8.47 |
| 2014-12-31 | -3.78 |
| 2013-12-31 | -0.70 |
| 2012-12-31 | -3.82 |
